Cargando…

Large HDL Subfraction But Not HDL-C Is Closely Linked With Risk Factors, Coronary Severity and Outcomes in a Cohort of Nontreated Patients With Stable Coronary Artery Disease: A Prospective Observational Study

High-density lipoprotein (HDL) is highly heterogeneous in its size and composition. Till now, the link of HDL subfractions to coronary risk is less clear. We aimed to investigate the associations of HDL subfractions with traditional risk factors (RFs), coronary severity, and outcomes in a cohort of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jian-Jun, Zhang, Yan, Li, Sha, Cui, Chuan-Jue, Zhu, Cheng-Gang, Guo, Yuan-Lin, Wu, Na-Qiong, Xu, Rui-Xia, Liu, Geng, Dong, Qian, Sun, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2016
Materias:	3400
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5291580/ https://www.ncbi.nlm.nih.gov/pubmed/26825910 http://dx.doi.org/10.1097/MD.0000000000002600

Ejemplares similares

Beneficial effects of high-density lipoprotein (HDL) on stent biocompatibility and the potential value of HDL infusion therapy following percutaneous coronary intervention
por: Liu, Jian-Di, et al.
Publicado: (2022)

Association of total cholesterol and HDL-C levels and outcome in coronary heart disease patients with heart failure
por: Zhao, Qin, et al.
Publicado: (2017)

HDL subfractions and very early CAD: novel findings from untreated patients in a Chinese cohort
por: Zhang, Yan, et al.
Publicado: (2016)

Associations of high HDL cholesterol level with all-cause mortality in patients with heart failure complicating coronary heart disease
por: Cai, Anping, et al.
Publicado: (2016)

Distribution of High-Density Lipoprotein Subfractions and Hypertensive Status: A Cross-Sectional Study
por: Zhang, Yan, et al.
Publicado: (2015)

Proprotein Convertase Subtilisin/Kexin type 9, C-Reactive Protein, Coronary Severity, and Outcomes in Patients With Stable Coronary Artery Disease: A Prospective Observational Cohort Study
por: Li, Jian-Jun, et al.
Publicado: (2015)

Subfractions of high-density lipoprotein (HDL) and dysfunctional HDL in chronic kidney disease patients
por: Rysz-Górzyńska, Magdalena, et al.
Publicado: (2016)

Association of HDL Subfraction Profile with the Progression of Insulin Resistance
por: Piko, Peter, et al.
Publicado: (2023)

Association of HDL subfraction profile with the progression of insulin resistance
por: Pikó, P, et al.
Publicado: (2023)

Risk Factors, Coronary Severity, Outcome and ABO Blood Group: A Large Chinese Han Cohort Study
por: Zhang, Yan, et al.
Publicado: (2015)

Association of HDL subfractions with cardiovascular risk in Hungarian general and Roma populations
por: Pikó, P, et al.
Publicado: (2022)

The value of HDL subfractions in predicting cardiovascular outcomes in untreated, diabetic patients with stable coronary artery disease: An age- and gender-matched case-control study
por: Zhang, Wei, et al.
Publicado: (2023)

Systemic Inflammatory Markers Are Closely Associated with Atherogenic Lipoprotein Subfractions in Patients Undergoing Coronary Angiography
por: Zhang, Yan, et al.
Publicado: (2015)

Corrigendum: The value of HDL subfractions in predicting cardiovascular outcomes in untreated, diabetic patients with stable coronary artery disease: an age- and gender-matched case-control study
por: Zhang, Wei, et al.
Publicado: (2023)

Effect of insulin analog initiation therapy on LDL/HDL subfraction profile and HDL associated enzymes in type 2 diabetic patients
por: Aslan, Ibrahim, et al.
Publicado: (2013)

Myeloperoxidase mediated HDL oxidation and HDL proteome changes do not contribute to dysfunctional HDL in Chinese subjects with coronary artery disease
por: Wang, Guisong, et al.
Publicado: (2018)

HDL Phospholipids, but Not Cholesterol Distinguish Acute Coronary Syndrome From Stable Coronary Artery Disease
por: Meikle, Peter J., et al.
Publicado: (2019)

Association of rs2000999 in the haptoglobin gene with total cholesterol, HDL-C, and LDL-C levels in Mexican type 2 diabetes patients
por: Suarez-Sanchez, Fernando, et al.
Publicado: (2019)

Assessing HDL Metabolism in Subjects with Elevated Levels of HDL Cholesterol and Coronary Artery Disease
por: Hancock-Cerutti, William, et al.
Publicado: (2021)

The profile of HDL-C subfractions and their association with cardiovascular risk in the Hungarian general and Roma populations
por: Piko, Peter, et al.
Publicado: (2022)

Influence of hypercholesterolemia and diabetes on long-term outcome in patients with stable coronary artery disease receiving percutaneous coronary intervention
por: Lin, Mao-Jen, et al.
Publicado: (2019)

Relation of plasma PCSK9 levels to lipoprotein subfractions in patients with stable coronary artery disease
por: Xu, Rui-Xia, et al.
Publicado: (2014)

Association between plasma ADAMTS-7 levels and severity of disease in patients with stable obstructive coronary artery disease
por: Yu, Jie, et al.
Publicado: (2016)

Large HDL(2) combined with inflammatory factors as superior predictors for coronary artery disease than small HDL(3)
por: Wu, Xiaoying, et al.
Publicado: (2021)

Prognostic indicators for the onset of ischaemic versus haemorrhagic stroke in stable coronary artery disease
por: Wang, Wei-Ting, et al.
Publicado: (2021)

Impact of estimated HDL particle size via the ratio of HDL-C and apoprotein A-I on short-term prognosis of diabetic patients with stable coronary artery disease
por: Hong, Li-Feng, et al.
Publicado: (2014)

Treatment of coronary pseudoaneurysm detected after percutaneous coronary intervention for chronic total occlusion: A case report
por: Li, Xudong, et al.
Publicado: (2023)

Effect of Shexiang Tongxin dropping pill on stable coronary artery disease patients with normal fractional flow reserve and coronary microvascular disease: A study protocol
por: Lu, Yanli, et al.
Publicado: (2020)

Chronic troponin elevation assessed by myocardial T1 mapping in patients with stable coronary artery disease
por: Segre, Carlos Alexandre W., et al.
Publicado: (2023)

Should fraction flow reserve be considered an important decision-making tool to stratify patients with stable coronary artery disease for percutaneous coronary intervention?: A meta-analysis
por: Bundhun, Pravesh Kumar, et al.
Publicado: (2017)

Triglycerides and low HDL cholesterol predict coronary heart disease risk in patients with stable angina
por: Caselli, Chiara, et al.
Publicado: (2021)

Decreased APOE-containing HDL subfractions and cholesterol efflux capacity of serum in mice lacking Pcsk9
por: Choi, Seungbum, et al.
Publicado: (2013)

Percutaneous coronary intervention for congenital absence of the right coronary artery with acute myocardial infarction: A case report and literature review
por: Liu, Wei-Chao, et al.
Publicado: (2020)

The renoprotective effects of simvastatin and atorvastatin in patients with acute coronary syndrome undergoing percutaneous coronary intervention: An observational study
por: Ma, Huan, et al.
Publicado: (2017)

MTHFR C677T gene polymorphism and the severity of coronary lesions in acute coronary syndrome
por: Li, Miao-Nan, et al.
Publicado: (2017)

Comparison of coronary artery bypass grafting and percutaneous coronary intervention for syphilitic coronary artery ostial lesions: A 4-year retrospective study
por: Han, Junyu, et al.
Publicado: (2020)

Associations of non-HDL-C and triglyceride/HDL-C ratio with coronary plaque burden and plaque characteristics in young adults
por: Akin, Fatih, et al.
Publicado: (2022)

Management of stable coronary artery disease and atrial fibrillation with anti-thrombotic therapy: A systematic review and meta-analysis
por: Malladi, Srikanth, et al.
Publicado: (2021)

The effect of weight loss on HDL subfractions and LCAT activity in two genotypes of APOA-II -265T>C polymorphism
por: Moradi, Masoumeh, et al.
Publicado: (2017)

HDL signaling and protection against coronary artery atherosclerosis in mice
por: Trigatti, Bernardo L, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ds6imm253qgm2e5rqru6r16t8p